Literature DB >> 26460986

Hospital Anxiety and Depression Scale: Factor Structure, Internal Consistency and Convergent Validity in Patients with Dizziness.

Erin G Piker1, David M Kaylie, Douglas Garrison, Debara L Tucci.   

Abstract

Psychiatric comorbidities, particularly anxiety-related pathologies, are often observed in dizzy patients. The Hospital Anxiety and Depression Scale (HADS) is a widely used self-report instrument used to screen for anxiety and depression in medical outpatient settings. The purpose of this study was to assess the factor structure, internal consistency and convergent validity of the HADS in an unselected group of patients with dizziness. The HADS and the Dizziness Handicap Inventory (DHI) were administered to 205 dizzy patients. An exploratory factor analysis was conducted and indicated a 3-factor structure, inconsistent with the 2-subscale structure (i.e. anxiety and depression) of the HADS. The total scale was found to be internally consistent, and convergent validity, as assessed using the DHI, was acceptable. Overall findings suggest that the HADS should not be used as a tool for psychiatric differential diagnosis, but rather as a helpful screener for general psychiatric distress in the two domains of psychiatric illness most germane in dizzy patients.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26460986     DOI: 10.1159/000438740

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  8 in total

Review 1.  Current diagnostic procedures for diagnosing vertigo and dizziness.

Authors:  Leif Erik Walther
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

2.  Role of Emotional Distress in Prolongation of Dizziness: A Cross-Sectional Study.

Authors:  Kyung Jin Roh; Min Ki Kim; Ji Hyung Kim; Eun Jin Son
Journal:  J Audiol Otol       Date:  2017-12-29

3.  In Older Patients Treated for Dizziness and Vertigo in Multimodal Rehabilitation Somatic Deficits Prevail While Anxiety Plays a Minor Role Compared to Young and Middle Aged Patients.

Authors:  Maren Dietzek; Sigrid Finn; Panagiota Karvouniari; Maja A Zeller; Carsten M Klingner; Orlando Guntinas-Lichius; Otto W Witte; Hubertus Axer
Journal:  Front Aging Neurosci       Date:  2018-10-30       Impact factor: 5.750

4.  Feasibility of integrating vestibular rehabilitation and cognitive behaviour therapy for people with persistent dizziness.

Authors:  Lene Kristiansen; L H Magnussen; B Juul-Kristensen; S Mæland; S H G Nordahl; A Hovland; T Sjøbø; K T Wilhelmsen
Journal:  Pilot Feasibility Stud       Date:  2019-05-20

5.  Efficacy of intergrating vestibular rehabilitation and cognitive behaviour therapy in persons with persistent dizziness in primary care- a study protocol for a randomised controlled trial.

Authors:  Lene Kristiansen; L H Magnussen; K T Wilhelmsen; S Mæland; S H G Nordahl; R Clendaniel; A Hovland; B Juul-Kristensen
Journal:  Trials       Date:  2019-10-07       Impact factor: 2.279

6.  How Healthcare Utilization Due to Dizziness and Vertigo Differs Between Older and Younger Adults.

Authors:  Tino Prell; Sigrid Finn; Hubertus Axer
Journal:  Front Med (Lausanne)       Date:  2022-02-16

7.  Self-Reported Measures Have a Stronger Association With Dizziness-Related Handicap Compared With Physical Tests in Persons With Persistent Dizziness.

Authors:  Lene Kristiansen; Liv H Magnussen; Kjersti T Wilhelmsen; Silje Maeland; Stein Helge G Nordahl; Anders Hovland; Richard Clendaniel; Eleanor Boyle; Birgit Juul-Kristensen
Journal:  Front Neurol       Date:  2022-07-15       Impact factor: 4.086

8.  Vestibular rehabilitation in multiple sclerosis: study protocol for a randomised controlled trial and cost-effectiveness analysis comparing customised with booklet based vestibular rehabilitation for vestibulopathy and a 12 month observational cohort study of the symptom reduction and recurrence rate following treatment for benign paroxysmal positional vertigo.

Authors:  J Marsden; M Pavlou; R Dennett; A Gibbon; R Knight-Lozano; L Jeu; C Flavell; J Freeman; D E Bamiou; C Harris; A Hawton; E Goodwin; B Jones; S Creanor
Journal:  BMC Neurol       Date:  2020-11-27       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.